IL-17 Cytokines Induce IκBζ in Dermal Fibroblasts to Promote Pro-Inflammatory Gene Expression in Psoriasis
Authors:
- Lejla SvrakaLSLejla Svraka
- Anna Skarnvad AndersenAAAnna Skarnvad Andersen
- Toke TouborgTTToke Touborg
- Thomas EmmanuelTEThomas Emmanuel
- Udayaraja GkUGUdayaraja Gk
- Haja N. KadarmideenHKHaja N. Kadarmideen
- Trine BertelsenTBTrine Bertelsen
- Christian VestergaardCVChristian Vestergaard
- Claus JohansenCJClaus Johansen
Open Access
- 28 January 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1297
Abstract
IκBζ (NFKBIZ) has been implicated as a key co-transcription factor in psoriasis pathogenesis. While its role in keratinocytes is well established, the involvement in dermal fibroblasts, another critical skin cell type, remains underexplored. This study characterizes cytokine-induced NFKBIZ regulation in human dermal fibroblasts in vitro and integrates spatial transcriptomics to determine NFKBIZ expression patterns in psoriatic skin biopsies. Primary dermal fibroblasts were stimulated with IL-17A, IL-17F, and TNF. Signaling pathways and gene regulation were examined using chemical inhibitors, siRNA knockdown, qPCR, and Western blotting. Additionally, spatial transcriptomics (CosMx™) assessed NFKBIZ expression in paired lesional and non-lesional psoriatic skin biopsies. Results showed significant upregulation of IκBζ expression in dermal fibroblasts following stimulation with both IL-17A and IL-17F. The NF-κB signaling pathway was identified as the primary regulator of NFKBIZ induction. NFKBIZ knockdown significantly reduced cytokine-induced expression of inflammatory mediators (CXCL8, CCL20, CCL2), confirming its regulatory role. Spatial transcriptomics further confirmed NFKBIZ expression in dermal fibroblasts in vivo, particularly in lesional psoriatic skin. This study establishes IκBζ as a critical modulator of inflammatory responses in dermal fibroblasts, expanding its recognized role beyond keratinocytes and immune cells, and highlights IκBζ inhibition as a potential therapeutic strategy.Keywords
Funding Information
- Aarhus University (2024-0233)
This publication has 36 references indexed in Scilit:
- Dermal fibroblast subsets and their roles in inflammatory and autoimmune skin diseasesJournal of Dermatological Science, 2025
- Fibroblasts in immune-mediated inflammatory diseases: The soil of inflammationClinical Immunology, 2023
- ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal FibroblastsJournal of Investigative Dermatology, 2022
- IκBζ is a key player in the antipsoriatic effects of secukinumabJournal of Allergy and Clinical Immunology, 2020
- Epithelial proliferation in inflammatory skin disease is regulated by tetratricopeptide repeat domain 7 (Ttc7) in fibroblasts and lymphocytesJournal of Allergy and Clinical Immunology, 2019
- A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasisCytokine, 2018
- Characterization of TNF-α– and IL-17A–Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζJournal of Investigative Dermatology, 2016
- Dermal fibroblast expression of stromal cell-derived factor-1 (SDF-1) promotes epidermal keratinocyte proliferation in normal and diseased skinProtein & Cell, 2015
- Involvement of insulin-like growth factor-I in psoriasis as a paracrine growth factor: dermal fibroblasts play a regulatory role in developing psoriatic lesionsArchives of Dermatological Research, 2000
- Establishment of Fibroblast CulturesCurrent Protocols in Cell Biology, 1998